Abstract:Currently there is no reliable nomogram to predict the overall survival (OS) for patients with esophageal squamous cancer (ESCC) after chemoradiation therapy followed by surgery. The purpose of this study is to develop the above nomogram through the correlation of pretreatment clinical features that are commonly indicated for prognosis. We searched through Surveillance, Epidemiology, and End Results (SEER) database. A criterion for the search is listed as follows: (1) patients diagnosed with pathologically proved ESCC; (2) patients diagnosed in 2010-2014(AJCC 2010 7th version); (3) patients with T1-4N0-3M0 disease; (4) patients underwent chemoradiation therapy followed by surgery. Age, ethnicity, sex, Primary Site of the tumor, T stage, N stage were recorded as clinical predictors. These predictors were used in multivariable logistic regression analysis based nomograms to estimate the probabilities of OS. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve. Analyses were performed with open-source statistical software R (version 3.2.1). There were 5,508 patients with ESCC diagnosed in 2010-2014, 326 patients were identified. A total of 41% of patients were male. A total of 62% were aged 50 to 70.72% and were in the white race. Proportion of the patients diagnosed in T1, T2, T3, and T4 were 15%, 18%, 63%, and 4%; 92% of the patients were in N0-1 stage; 88.3% of the tumor were located in middle and lower third of esophagus; only 4% had overlapping lesion of esophagus. The 3-year and 4-year OS for the entire cohort of the patients were 53%, 47% with the median survival time of 45 months. Median survival of male and female patients were 38 months vs. 54 months (p=0.024); 3 year survival of patients with white race and other race were 56% vs. 45%, p=0.050; 3 year OS for patients with T1-2 and T3-4 stage were 60.8% vs. 52.4%, p = 0.198. For patients with N0, N1, N2, and N3 stage, 3-year OS were 87.3%, 54.3%, 37.1%, and 0%, p < 0.001. Primary site of the tumor was not the prognostic factors. Nomograms were developed for the predicted OS with age, sex, ethnicity, T stage, and N stage. The calibration curve for probabilities showed relatively good agreement between prediction by nomogram and actual observation. The C-index of the nomograms for predicting for predicting OS is 0.63. The risk of having one of the indications of adjuvant radiation therapy increased with increases in predictors except for clinical T stage. Using clinical information, we produced nomograms, which may relatively accurately predict the probabilities of overall survival for patients with esophageal squamous cancer after chemoradiation therapy followed by surgery. This nomogram may help individualize initial treatment options.

Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy

A neotype nomogram based on accessible clinical indicators to predict the overall survival of esophageal cancer patients underwent radical resection

A Reliable Nomogram is Identified to Predict the Overall Survival for Patients with Esophageal Squamous Cancer after Chemoradiation Therapy Followed by Surgery

Nomogram to predict overall survival for patients with non-metastatic cervical esophageal cancer: a SEER-based population study

Prognostic Nomogram for Previously Untreated Patients with Esophageal Squamous Cell Carcinoma after Esophagectomy Followed by Adjuvant Chemotherapy

Analysis of prognostic factors and nomogram for predicting survival for patients with locally resectable esophageal cancer after preoperative chemoradiation therapy

Development and validation of a prognostic nomogram for esophageal cancer patients based on SEER Asian population

Construction a new nomogram prognostic model for predicting overall survival after radical resection of esophageal squamous cancer.

A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging

The Evaluation of a SEER-Based Nomogram in Predicting the Survival of Patients Treated with Neoadjuvant Therapy Followed by Esophagectomy

Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.

Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients

Nomogram to Predict the Overall Survival for Patients Underwent Preoperative Radiation Therapy with Chemotherapy

Development of a nomogram for overall survival in patients with esophageal carcinoma: A prospective cohort study in China

A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study

Prognostic Nomogram for Predicting Long-Term Overall Survival of Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Plus Surgery: A Population-Based Study

Nomogram Prediction for the Survival of the Patients with Small Cell Esophageal Cancer

Prognostic prediction model for patients with pathological T1N0 stage esophageal squamous cell carcinoma undergone esophagectomy

Nomogram for Predicting Survival after Lymphatic Metastasis in Esophageal Cancer: A SEER Analysis.